Granulocyte clinical trials
How each study uses Granulocyte is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Granulocyte studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Granulocytes
- 2
Studies by the year they started
5 studies that test it; most in 2009 (1)
| Year | Studies |
|---|---|
| 2009 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 5
University of Manchester (1) · Dipnarine Maharaj (1) · Chinese PLA General Hospital (1) · Wuxi People's Hospital (1) · Shanghai East Hospital (1)
Often tested with
Tested in the same studies.
Human leukocyte (1) · Azacitidine (1) · Cytarabine (1) · Aclacinomycins (1) · Tucidinostat (1) · Venetoclax (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1, 1 in phase 3
Studies that test Granulocyte, phase 3 first.
- Sep 2027Venetoclax-Azacitidine in Combination With Chidamide and CAG in Fit Older Patients With Acute Myeloid LeukaemiaPhase 3 · Chinese PLA General Hospital
Studies
Open first, then newest update. How each study uses Granulocyte is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- Venetoclax-Azacitidine in Combination With Chidamide and CAG in Fit Older Patients With Acute Myeloid LeukaemiaRecruitingPhase 3Chinese PLA General HospitalNCT07514936Written as Azacytidine; Cytarabine; Aclacinomycin; Chidamide; Venetoclax; Granulocyte
- A Study Using White Blood Cells From Healthy Donors To Treat Solid CancersEnrolling by invitationPhase 1/2Dipnarine MaharajNCT00900497Written as White Blood Cells/Granulocytes
- Clinical Study on the Treatment of Advanced Recurrent Tumors With Anticancer Mouse Characteristic Human NeutrophilsRecruitingPhase 1Wuxi People's HospitalNCT06240767Written as Granulocyte infusion
- Granulocyte Transfusions After Umbilical Cord Blood TransplantActive, not recruitingNot applicableUniversity of ManchesterNCT05425043Written as Granulocytes
- Clinical Study of Granulocyte Infusion for Advanced CancerStatus unknownPhase 1/2Shanghai East HospitalNCT04124666Written as Granulocytes